SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019983
Filing Date
2021-08-16
Accepted
2021-08-16 08:01:00
Documents
47
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rvph20210831_10q.htm   iXBRL 10-Q 653038
2 EXHIBIT 4.1 ex_268126.htm EX-4.1 103818
3 EXHIBIT 4.2 ex_268127.htm EX-4.2 106965
4 EXHIBIT 4.3 ex_268128.htm EX-4.3 125910
5 EXHIBIT 31.1 ex_262216.htm EX-31.1 9172
6 EXHIBIT 31.2 ex_262217.htm EX-31.2 9183
7 EXHIBIT 32.1 ex_262218.htm EX-32.1 6957
  Complete submission text file 0001437749-21-019983.txt   3624331

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA rvph-20210630.xsd EX-101.SCH 34337
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rvph-20210630_cal.xml EX-101.CAL 17662
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvph-20210630_def.xml EX-101.DEF 242354
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvph-20210630_lab.xml EX-101.LAB 221697
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvph-20210630_pre.xml EX-101.PRE 260196
13 EXTRACTED XBRL INSTANCE DOCUMENT rvph20210831_10q_htm.xml XML 350092
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 211174601
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences